Reports
Significant savings for patients & payers
Our 2024 Annual Savings Report details the savings realized by CivicaScript payer members and patients and the broader market impact as we introduced our low-cost treatments.
These new data continue to validate the success of our business model in delivering on our mission: to make generic medicines and biosimilars available and affordable to everyone. Read more >
CivicaScript model delivers significant patient and payer savings. Learn more >
